According to the latest MAT Q3 2018 figures from DB6 – released at the end of last week – the global OTC market maintained 4.3% growth in the year to end-September 2018. As our graph below shows, the world’s two largest OTC markets, USA and China, still overshadow the rest of the Top 10 and growth for both markets in Q3 was faster than any of the other Top 5 countries.
US growth was up slightly to 2.6% (vs 2.5% MAT Q2 2018), where a slower performance in CCA was offset by improvements across all other major categories. Asia-Pacific grew by 4.9%, with mixed performances among the top markets. While growth remained steady in China and India, Japan sales continued to weaken (+0.3% vs +0.6% MAT Q2 2018) and Australia remained subdued (+0.9%).
Top 10 CHC markets MAT Q3 2018
Half of the Top 10 markets are still located in Europe, though growth for the two biggest – Germany and Russia – was in the 1-2% range in Q3, while for the other three – France, Italy and the UK – it was in the 2-3% range. Overall, Europe’s OTC performance remained constant, increasing by 2.9%. Western Europe was up by 2.4%, with France continuing to advance but Germany hindered by weak CCA sales, while growth in Central & Eastern Europe was up 4.1%.
Middle East & Africa growth was stable at 6.6%, with double-digit growth in Turkey (+12.9%) still behind the strong upturn. Latin America (+12.8%) growth remains driven by high levels of inflation, with the largest market Brazil up by 10.8%. Commenting on the Q3 results, Nicholas Hall said: “This [Brazil] is the world’s 8th largest CHC market, and will probably overtake Italy in 2019. The economy is totally flat and inflation is running at almost 5%; in that sense CHC is holding up well in this very important market.“
Nicholas Hall’s DB6 MAT Q3 2018 figures are now available! DB6 features over 24,000 records and covers 10,000+ brands and more than 2,500 companies, offering complete coverage across 64 countries. To find out more about this essential service, or for a free demonstration, please contact kayleigh.griffinhooper@NicholasHall.com